Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03954717 · ClinicalTrials.gov registry record
Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program
A clinical trial of Multiple Sclerosis, sponsored by Shepherd Center, Atlanta GA.
- Completed
- Registry status
- 111
- Enrollment target
- 1
- Study location
NCT03954717 is a study of Multiple Sclerosis that has completed, run by Shepherd Center, Atlanta GA. The registered enrollment target is 111 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03954717, a study of Multiple Sclerosis, has completed, sponsored by Shepherd Center, Atlanta GA.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
The study evaluates the efficacy of the CAN DO Program for improving health, wellness, and quality of life in people with MS, and compares outcomes between people with MS who participate in the CAN DO Program to a control group of people with MS who do not participate in the CAN DO Program. The study also evaluates the impact of the CAN DO Program on support partners.
Conditions Studied
Interventions
- BEHAVIORAL Shepherd CAN DO Program
Study Locations (1)
Georgia
- Shepherd Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2019-05-14 |
| Est. Completion | 2022-03-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03954717
The ClinicalTrials.gov registry entry for NCT03954717 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (81% lower). The listed sponsor is Shepherd Center, Atlanta GA, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Shepherd CAN DO Program is the first listed.
NCT03954717 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03954717 about?
NCT03954717 is a clinical study titled "Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program". The study evaluates the efficacy of the CAN DO Program for improving health, wellness, and quality of life in people with MS, and compares outcomes between people with MS who participate in the CAN DO Program to a control group of people with MS who do not participate in the CAN DO Program. The stud...
What is the current status of trial NCT03954717?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2019-05-14. Estimated completion is 2022-03-11.
What conditions does trial NCT03954717 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT03954717?
The interventions under investigation include: Shepherd CAN DO Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03954717?
This trial is sponsored by Shepherd Center, Atlanta GA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03954717 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.